Gemtesa (vibegron) has an elimination half-life of roughly 30 hours, meaning it takes about 6 to 7 days after your last dose for the drug to clear almost entirely from your system. That estimate comes from the standard pharmacology rule that a medication is considered effectively eliminated after five half-lives, which for Gemtesa works out to approximately 150 to 155 hours.
How Gemtesa Leaves Your Body
After you swallow a 75 mg tablet, Gemtesa reaches its peak concentration in your blood within about 1 to 3 hours. From there, levels gradually decline as your body processes the drug through two main routes: roughly 59% is eliminated through urine and about 36% through stool. This split means both your kidneys and liver play a role in clearing it.
Because the half-life is around 30 hours, each day that passes after your last pill cuts the remaining drug roughly in half. After one day, about half is still circulating. After two and a half days, roughly a quarter remains. By day 6 or 7, less than 3% of the original dose is left, which is the threshold most pharmacologists use to consider a drug “out of your system.”
Steady State and Why It Matters
If you’ve been taking Gemtesa daily for more than a week, your body has reached what’s called steady state, where each new dose tops off what’s still lingering from previous doses. Steady-state concentrations of vibegron are reached within about 7 days of once-daily dosing, and FDA review data shows that 90% of steady-state exposure is achieved after just 3 to 5 days.
This buildup doesn’t dramatically change how long it takes to fully clear once you stop. The half-life stays the same regardless. But it does mean the starting concentration on the day you quit is higher than it would be after a single dose, so the tail end of elimination may stretch slightly. For most people, expect the drug to be functionally gone within about a week of your last tablet.
Factors That Can Slow Clearance
Your individual clearance time can shift depending on kidney and liver function, since Gemtesa relies on both organs for elimination. People with moderate to severe kidney impairment or liver disease may process the drug more slowly, meaning it could linger a day or two longer than the average estimate. Age also plays a role: older adults tend to metabolize medications at a slower pace, which can modestly extend the timeline.
Body composition, hydration, and other medications you take can also influence how quickly vibegron is broken down. If you’re taking drugs that affect the same liver enzymes responsible for processing Gemtesa, clearance may be faster or slower depending on the interaction. None of these factors are likely to change the timeline by more than a couple of days in either direction for most people.
What Happens to Symptoms After Stopping
Knowing when the drug leaves your bloodstream is one thing. Knowing when overactive bladder symptoms return is another, and the two timelines don’t always match. While Gemtesa-specific discontinuation data is limited, research on the broader class of OAB medications gives a useful picture.
In a prospective study of women who had improved on OAB medication, symptoms were assessed four weeks after stopping treatment. The results showed partial benefit carried over: average daily urinary frequency went from 11.2 at baseline to 7.3 on treatment, then crept back up to 8.3 a month after stopping. Nighttime urination followed the same pattern, rising from 0.4 episodes on treatment to 0.8 after discontinuation, still better than the 1.6 average before treatment began.
About 35% of patients in that study sought re-treatment within a month of stopping. Those over 55 or with more severe urgency symptoms were more likely to need medication again. Patients whose overactive bladder was driven by involuntary bladder muscle contractions tended to see symptoms return faster than those without that underlying pattern. The takeaway: the drug clears your body in roughly a week, but symptom relief may partially persist for weeks before gradually fading.